Estimating the costs of esophageal cancer screening, early diagnosis and treatment in three high risk areas in China

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 5, 2011, Pages 1245-1250

  Yang, Juan ^a   Wei, Wen Qiang ^b   Niu, Jin ^a   He, Yu Tong ^c   Liu, Zhi Cai ^d   Song, Guo Hui ^e   Zhao, De Li ^f   Qiao, You Lin ^b   Yang, Chun Xia ^a  

^a SICHUAN UNIVERSITY   (China)

^b CANCER HOSPITAL   (China)

^c HEBEI MEDICAL UNIVERSITY   (China)

^d Linzhou Cancer Registry   (China)

^e Cixian Cancer Institute   (China)

^f Feicheng People's Hospital   (China)

Author keywords

Esophageal cancer; Micro costing; Screening and treatment cost

Indexed keywords

EID: 84863298482     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Barnett PG (2009). An improved set of standards for finding cost for cost-effectiveness analysis. Med Care, 47, S82-S88.
2. Barton GR, Bloor KE, Marshall DH, et al (2003). Healthservice costs of pediatric cochlear implantation: multi-center analysis. Int J Pediatric Otorhinolaryngol, 67, 141-9.
3. Cheng TM (2008). Interview: China's latest health reforms: A conversation with Chinese health minister Chen Zhu. Health Affairs, 27, 1103-10.
4. China Statistical Yearbook-2008 (2008). Available from: http://www.stats.gov.cn/tjsj/ndsj/2008/indexch.htm
5. Dawsey SM, Shen Q, Nieberg RK, et al (1997). Studies of esophageal balloon cytology in Linxian, China. Cancer Epidemiol Biomarkers Prev, 6, 121-30.
6. Dawsey SM, Fleischer DE, Wang G.Q, et al (1998). Mucosal iodine staining improves endoscopic visualization of squamous dysplasia and squamous cell carcinoma of the esophagus in Linxian, China. Cancer, 83, 220-31.
7. Finkler SA (1982). The distinction between cost and charges. Ann Intern Med, 96, 102-9.
8. Frick KD (2009). Microcosting Quantity Data Collection Methods. Med Care, 47, S76-S81.
9. Goldhaber-Fiebert JD, Goldie SJ (2006). Estimating the cost of cervical cancer screening in five developing countries. Cost Eff Resour Alloc, 4, 13.
10. Griffith GL, Tudor-Edwards R, Gray J, et al (2005). A micro costing of NHS cancer genetic services. Br J Cancer, 92, 60-71.
11. Guan RY, Song LQ (1987). Endoscopic surveys in high-risk and low-risk populations for esophageal cancer in China with special reference to precursors of esophageal cancer. Endoscopy, 19, 91-5.
12. Guo HQ, Wei WQ, Lv N, et al (2009). Liquid-based cytology for esophageal carcinoma screening. Chin J Cancer, 28, 1243-7.
13. Jemal A, Siegel R, Ward E, et al (2006). Cancer Statistics, 2006. CA Cancer J Clin, 56, 106-30.
14. Johns B, Baltussen R, Hutuvessy R (2003). Program costs in the economic evaluation of health interventions. Cost Eff Resour Alloc, 1,1.
15. Karlsson G, Johannesson M (1998). Cost-effectiveness analysis and capital costs. Soc Sci Med, 46, 1183-91.
16. Liu ZR, Wei WQ, Huang YQ, et al (2006). Economic Evaluation of "Early Detection and Treatment of Esophageal Cancer". Chin J Cancer, 25, 200-3.
17. Lv SH, Li BY, Wei WQ, et al (2010). Cost ananlysis on esophageal cancer treatment among screening residents in Linzhou of Henan province. Modern Preventive Medicine, 37, 3667-9.
18. NCCN clinical practice guidelines in oncology TM esophageal cancer (2009). Available from: http://www.nccn.org/
19. Pan QJ, Roth MJ, Guo HQ, et al (2008). Cytologic detection of esophageal squamous cell carcinoma and its precursor lesions using balloon samplers and liquid-based cytology in asymptomatic adults in Linxian, China. Acta Cytol, 52, 14-23.
20. Parkin DM, Bray F, Ferlay J, Pisani P (2005). Global cancer statistics 2002. CA Cancer J Clin, 55, 74-108.
21. Philip M, Julia FR (2006). Cost-effectiveness analysis for priority setting. In "Disease Control Priorities in Developing Countries", Jamison DT, Breman JG, Measham AR, et al. The World Bank, Version 2. Oxford University Press and the World Bank, Washington DC, 271-85.
22. Qin DX, Wang GQ, Yuan FL, et al (1988). Screening for upper digestive tract cancer with an occult blood bead detector. Investigation of a normal north China population. Cancer, 62, 1030-4.
23. Qin DX, Wang GQ, Zuo JH (1992). Experiences on primary screening of esophageal and gastric cancers with occultblood bead detector. Chin J Oncol, 14, 77.
24. Roth MJ, Liu SF, Dawsey SM, et al (1997). Cytologic detection of esophageal squamous cell carcinoma and precursor lesions using balloon and sponge samplers in asymptomatic adults in Linxian, China. Cancer, 80, 2047-59.
25. Sant M, Aareleid T, Berrino F, et al (2003). The EUROCARE Working Group. EUROCARE-3: survival of cancer patients diagnosed 1990-94-results and commentary. Annals of Oncology, 14 (Suppl 5), v61-v118.
26. Shen Q, Wang DY, Liu SF, et al (1993). Cytologic screening for esophageal cancer: results from 12,877 subjects from a high risk population in china. Int J Cancer, 54, 185-8.
27. Shu YJ (1983). Cytopathology of the esophagus. An overview of esophageal cytopathology in China. Acta Cytol, 27, 7-16.
28. Shwartz M, Young DW, Siegrist R (1995). The ratio of costs to charges: how good a basis for estimating costs? Inquiry, 32, 476-81.
29. Tuncer AM (2010). Asian Pacific Organization for Cancer Prevention Cancer report 2010. Ankara: New Hope in Health Foundation, 2010.
30. Wang GQ (1989). Data analysis of gastroscopic screening among 2 000 population. Chin J Oncol, 11, 201-3.
31. Wang GQ (2001). 30-year experiences on early detection and treatment of esophageal cancer in high risk areas. Chin Med Sci J, 23, 69-72.
32. Wang GQ, Jiao GG, Chang FB, et al (2004). Long-term results of operation for 420 patients with early squamous cell esophageal carcinoma discovered by screening. Ann Thorac Surg, 77, 1740-4.
33. Wang GQ, Abnet CC, Shen Q, et al (2005). Histological precursors of oesophageal squamous cell carcinoma: results from a 13 year prospective follow up study in a high risk population. Gut, 54, 187-92.
34. Wang SJ, Zhang LW, Wen DG, et al (2007). Analysis of endoscopic screening for the natural history of precancerous lesions in esophagus and cardia. Chinese Journal of Clinical Oncology, 34, 370-3.
35. World Health Organization: WHO-CHOICE (2003). Available from: http://www.who.int/choice/publications/p_2003_ generalised_cea.pdf
36. World Health Organization: Purchasing Power Parity 2005 (2005). Available from: http://www.who.int/choice/costs/ppp/en
37. Yu JJ, Liu YT, Tang LM (2003). Discussion about the depreciation of medical equipment. Information of Medical Equipment, 18, 52-7.